These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17287336)
1. Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates. Marsh JW; O'Leary MM; Shutt KA; Harrison LH J Clin Microbiol; 2007 Apr; 45(4):1333-5. PubMed ID: 17287336 [TBL] [Abstract][Full Text] [Related]
2. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241 [TBL] [Abstract][Full Text] [Related]
3. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil. Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914 [TBL] [Abstract][Full Text] [Related]
4. Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China. Yang L; Shao Z; Zhang X; Xu L; Peng J; Xu X; Liang X; Qi Y; Jin Q J Infect; 2008 Mar; 56(3):211-8. PubMed ID: 18215423 [TBL] [Abstract][Full Text] [Related]
5. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004. de Filippis I; de Andrade CF; Silva L; Prevots DR; Vicente AC Infect Immun; 2007 Jul; 75(7):3683-5. PubMed ID: 17502397 [TBL] [Abstract][Full Text] [Related]
6. Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms. Claus H; Elias J; Meinhardt C; Frosch M; Vogel U J Clin Microbiol; 2007 Sep; 45(9):2960-4. PubMed ID: 17626167 [TBL] [Abstract][Full Text] [Related]
7. Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines. Rojas E; Hoyos J; Oldfield NJ; Lee P; Flint M; Jones CH; Ala'Aldeen DA; Jansen KU; Anderson AS PLoS One; 2015; 10(7):e0132140. PubMed ID: 26147212 [TBL] [Abstract][Full Text] [Related]
8. Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease. Bennett DE; Cafferkey MT J Clin Microbiol; 2006 Mar; 44(3):1127-31. PubMed ID: 16517911 [TBL] [Abstract][Full Text] [Related]
9. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine. Bai X; Borrow R Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270 [TBL] [Abstract][Full Text] [Related]
10. Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease. Greiner O; Berger C; Day PJ; Meier G; Tang CM; Nadal D J Clin Microbiol; 2002 Nov; 40(11):3917-21. PubMed ID: 12409352 [TBL] [Abstract][Full Text] [Related]
11. Antigen sequence typing of outer membrane protein (fetA) gene of Neisseria meningitidis serogroup A from Delhi & adjoining areas. Dwivedi S; Das BK; Kapil A; Sood S; Chaudhry R; Gupta S; Deb M; Nair D; Aneja S Indian J Med Res; 2014 Dec; 140(6):766-9. PubMed ID: 25758575 [TBL] [Abstract][Full Text] [Related]
12. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013. Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205 [TBL] [Abstract][Full Text] [Related]
13. Variation of the factor H-binding protein of Neisseria meningitidis. Brehony C; Wilson DJ; Maiden MCJ Microbiology (Reading); 2009 Dec; 155(Pt 12):4155-4169. PubMed ID: 19729409 [TBL] [Abstract][Full Text] [Related]
15. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa. Mothibeli KM; du Plessis M; von Gottberg A; Murphy E; Hoiseth SK; Zlotnick G; Klugman KP Vaccine; 2011 Mar; 29(11):2187-92. PubMed ID: 21144918 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil. de Filippis I; de Lemos AP; Hostetler JB; Wollenberg K; Sacchi CT; Dunning Hotopp JC; Harrison LH; Bash MC; Prevots DR PLoS One; 2012; 7(3):e33016. PubMed ID: 22431994 [TBL] [Abstract][Full Text] [Related]
17. Antigenic shift and increased incidence of meningococcal disease. Harrison LH; Jolley KA; Shutt KA; Marsh JW; O'Leary M; Sanza LT; Maiden MC; J Infect Dis; 2006 May; 193(9):1266-74. PubMed ID: 16586364 [TBL] [Abstract][Full Text] [Related]
18. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine. Sorhouet Pereira C; Regueira M; Mollerach M J Med Microbiol; 2008 Mar; 57(Pt 3):338-342. PubMed ID: 18287297 [TBL] [Abstract][Full Text] [Related]
19. Assessment of vaccine potential of the Neisseria-specific protein NMB0938. Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688 [TBL] [Abstract][Full Text] [Related]
20. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. Kugelberg E; Gollan B; Farrance C; Bratcher H; Lucidarme J; Ibarz-Pavón AB; Maiden MC; Borrow R; Tang CM PLoS One; 2010 Feb; 5(2):e9413. PubMed ID: 20195528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]